Literature DB >> 19306994

Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.

Nowruz Delirezh1, Seyed Mohammad Moazzeni, Fazel Shokri, Mohammad Ali Shokrgozar, Morteza Atri, Parviz Kokhaei.   

Abstract

Dendritic cell (DCs) based immunotherapy has received increased interest in the treatment of specific malignancies including breast cancer. In this in vitro study, T cell responses, which are induced by monocyte-derived DCs pulsed with apoptotic breast tumor cells (ApTC), were analyzed in terms of proliferation, specific cytotoxicity, and cytokine release. Nylon wool-enriched T lymphocytes from five patients with breast cancer stimulated with monocyte-derived DCs pulsed with apoptotic tumor cells in vitro and their proliferation response were analyzed by [(3)H] thymidine uptake and specific cytotoxic activity of tumor antigen-primed T cells after three rounds of weekly stimulation by flow cytometry. Interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) cytokine release assay was carried out 24h after the last stimulation. The supernatant from primed T cells was collected and analyzed using commercially available ELISA kits. T cell proliferation assays revealed that DCs pulsed with apoptotic tumor cell could stimulate an autologous T cell proliferation response with stimulation indices of 5-21. The T cell-mediated cytotoxicity assay demonstrated that tumor antigen-primed T cells could kill significantly more autologous tumor cells than normal cells (P<0.05). These cells had variable amounts of cytotoxic activity against K562 cells. Primed T cells released both IFN-gamma and IL-4 in response to re-stimulation by antigen-pulsed DCs, but were dominated by IFN-gamma production in two out of five patients and IL-4 production in three out of five patients. In conclusion, our results suggested that DCs pulsed with apoptotic breast tumor cells could elicit effective specific antitumor T cell responses in vitro. Therefore, vaccination with DCs pulsed with apoptotic tumor cells may be considered as a novel strategy for immunotherapy of patients with breast cancer refractory to standard modalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19306994     DOI: 10.1016/j.cellimm.2009.02.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  15 in total

1.  Phenotypic and functional comparison of two distinct subsets of programmable cell of monocytic origin (PCMOs)-derived dendritic cells with conventional monocyte-derived dendritic cells.

Authors:  Babak Beikzadeh; Nowruz Delirezh
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

2.  Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Authors:  Fang Hou; Qi-Ming Huang; Dan-Ning Hu; Jost B Jonas; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Generation of mature monocyte-derived dendritic cells in the presence of heparin and monocyte conditioned medium: phenotypic and functional comparison.

Authors:  Nowruz Delirezh; Leila Majedi; Siamak Asri Rezaei; Hadi Ranjkeshzadeh
Journal:  Iran Biomed J       Date:  2011

4.  Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8(+) T cells to protect against histoplasmosis.

Authors:  Shih-Hung Hsieh; Jr-Shiuan Lin; Juin-Hua Huang; Shang-Yang Wu; Ching-Liang Chu; John T Kung; Betty A Wu-Hsieh
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

5.  Use of antigen-primed dendritic cells for inducing antitumor immune responses in vitro in patients with non-small cell lung cancer.

Authors:  Irina Obleukhova; Nataliya Kiryishina; Svetlana Falaleeva; Julia Lopatnikova; Vasiliy Kurilin; Vadim Kozlov; Aleksander Vitsin; Andrey Cherkasov; Ekaterina Kulikova; Sergey Sennikov
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

6.  Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.

Authors:  Abbas Ali Imani Fooladi; Raheleh Halabian; Mehdi Mahdavi; Mohsen Amin; Hamideh Mahmoodzadeh Hosseini
Journal:  Tumour Biol       Date:  2015-08-06

7.  Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models.

Authors:  Ze-Yu Wang; Yun Xing; Bin Liu; Lei Lu; Xiao Huang; Chi-Yu Ge; Wen-Jun Yao; Mao-Lei Xu; Zhen-Qiu Gao; Rong-Yue Cao; Jie Wu; Tai-Ming Li; Jing-Jing Liu
Journal:  Chin J Cancer       Date:  2012-03-27

8.  Comparison the effects of two monocyte isolation methods, plastic adherence and magnetic activated cell sorting methods, on phagocytic activity of generated dendritic cells.

Authors:  Nowruz Delirezh; Ehsan Shojaeefar; Parva Parvin; Behnaz Asadi
Journal:  Cell J       Date:  2013-08-24       Impact factor: 2.479

9.  Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.

Authors:  Min-Ho Park; Deok-Hwan Yang; Mi-Hyun Kim; Jae-Hong Jang; Yoon-Young Jang; Youn-Kyung Lee; Chun-Ji Jin; Than Nhan Nguyen Pham; Truc Anh Nguyen Thi; Mi-Seon Lim; Hyun-Ju Lee; Cheol Yi Hong; Jung-Han Yoon; Je-Jung Lee
Journal:  Cancer Res Treat       Date:  2011-03-31       Impact factor: 4.679

10.  Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.

Authors:  Peng Zhang; Shuhong Yi; Xi Li; Ruilei Liu; Hua Jiang; Zenan Huang; Yu Liu; Juekun Wu; Yong Huang
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.